PBM - Princeton BioMeditech Corporation
   Home     Products     How to Buy     Jobs     About PBM    

Simple Tests for Better Living

Cardiac Markers DXpress Reader Point-of-Care Analyzer Fertility
Infectious Disease Drugs of Abuse Veterinary Diagnostics
Food and Environmental Diagnostics Tumor Markers Other
  News and Events

  New Product Announcement

COVID-19 - Feb 2021
Rapid SARS-CoV-2 and Influenza A+B Antigen Combo Test receives FDA Emergency Use Authorization.

PBM and LifeSign introduce the first visually read combo test with EUA. Developed and Made in USA. More info @ LifeSign.

  Important Documents

  Status™ COVID-19/Flu A&B Ag

Instructions for Use [PDF]

Quick Reference Instructions [PDF]

Fact Sheet for Patients [PDF]

Fact Sheet for Healthcare Providers [PDF]

  BioSign® Flu A+B

Annual Reactivity Testing Data, 2019-2020-2021 [PDF]

  Quality & Regulatory


Princeton BioMeditech Corporation is a world leader in rapid, point-of-care diagnostics. Utilizing its patented technologies, PBM has developed and introduced an extensive menu of over 70 different one-step/rapid tests.

PBM is a registered FDA Medical Device Establishment operating under cGMP and is certified under ISO 13485:2016. We market products with FDA 510(k) clearance in the U.S., CMDCAS in Canada, CE mark in the European Union and other regulatory approvals and registrations as necessary in other countries. Learn about us and let us know how we can assist you.
All contents copyright © 1997-2015 Princeton BioMeditech Corporation. All rights reserved. Terms of Use